Table of Contents

1. Executive Summary

2. United States Diabetes Population & Insulin Users Analysis (2011 – 2022)
2.1 Overall Diabetes Population
2.2 Insulin Users

3. United States – Insulin Pen Users Trend & Analysis (2011 – 2022)
3.1 Insulin Pen Users & Forecast
3.1.1 Reusable (Cartridge) Insulin Pen Users
3.1.2 Prefilled (Disposable) Insulin Pen Users
3.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share

4. United States – Insulin Pen Market Trend & Analysis (2011 – 2022)
4.1 Insulin Pen Market & Forecast
4.1.1 Reusable (Cartridge) Insulin Pen Market
4.1.2 Prefilled (Disposable) Insulin Pen Market
4.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share

5. Key Drivers and Inhibitors of the United States Insulin Pen Market
5.1 Market Drivers
5.2 Inhibitors

6. United States Insulin Pen Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. Key Companies Analysis
7.1 Novo Nordisk
7.1.1 Business Overview
7.1.2 Insulin Pen – Products Portfolio
7.1.3 Insulin Pen – Latest Development & Trends
7.2 Eli Lilly
7.2.1 Business Overview
7.2.2 Insulin Pen – Products Portfolio
7.2.3 Insulin Pen – Latest Development & Trends
7.3 Sanofi
7.3.1 Business Overview
7.3.2 Insulin Pen – Products Portfolio
7.4 Owen Mumford
7.4.1 Business Overview
7.4.2 Insulin Pen – Products Portfolio

Table of Contents

1. Executive Summary

2. United States Diabetes Population & Insulin Users Analysis (2011 – 2022)
2.1 Overall Diabetes Population
2.2 Insulin Users

3. United States – Insulin Pen Users Trend & Analysis (2011 – 2022)
3.1 Insulin Pen Users & Forecast
3.1.1 Reusable (Cartridge) Insulin Pen Users
3.1.2 Prefilled (Disposable) Insulin Pen Users
3.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share

4. United States – Insulin Pen Market Trend & Analysis (2011 – 2022)
4.1 Insulin Pen Market & Forecast
4.1.1 Reusable (Cartridge) Insulin Pen Market
4.1.2 Prefilled (Disposable) Insulin Pen Market
4.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share

5. Key Drivers and Inhibitors of the United States Insulin Pen Market
5.1 Market Drivers
5.2 Inhibitors

6. United States Insulin Pen Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. Key Companies Analysis
7.1 Novo Nordisk
7.1.1 Business Overview
7.1.2 Insulin Pen – Products Portfolio
7.1.3 Insulin Pen – Latest Development & Trends
7.2 Eli Lilly
7.2.1 Business Overview
7.2.2 Insulin Pen – Products Portfolio
7.2.3 Insulin Pen – Latest Development & Trends
7.3 Sanofi
7.3.1 Business Overview
7.3.2 Insulin Pen – Products Portfolio
7.4 Owen Mumford
7.4.1 Business Overview
7.4.2 Insulin Pen – Products Portfolio